Financial Summary (All financials)
| In millions of CNY, except per share items | Jun-30-23 | Dec-31-22 | Jun-30-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 7,448.9 | 12,110.5 | 33,605.9 | 40,826.5 | 35,129.5 | 29,746.3 | 25,042.6 | 26,472.9 |
| Revenue growth | -77.8% | -70.3% | | 16.2% | 18.1% | 18.8% | -5.4% | 23.7% |
| Cost of goods sold | 6,232.1 | 10,320.5 | 28,607.5 | 34,168.7 | 28,957.8 | 24,314.6 | 21,528.9 | 23,481.4 |
| Gross profit | 1,216.8 | 1,790.1 | 4,998.4 | 6,657.8 | 6,171.7 | 5,431.7 | 3,513.7 | 2,991.6 |
| Gross margin | 16.3% | 14.8% | 14.9% | 16.3% | 17.6% | 18.3% | 14.0% | 11.3% |
| Selling, general and administrative | | | | | | | | |
| Sales and marketing | 444.4 | 1,055.3 | 3,007.0 | 2,856.5 | 2,474.0 | 2,250.3 | 1,708.3 | 1,901.4 |
| Research and development | 57.1 | 105.1 | 294.7 | 461.6 | 389.2 | 324.4 | 366.6 | 294.1 |
| General and administrative | 259.9 | 508.7 | 1,788.4 | 1,963.6 | 1,409.4 | 1,059.0 | 779.4 | 470.8 |
| EBITA | 6,644.8 | 149.1 | 28,365.6 | 1,447.9 | 1,856.6 | 1,775.8 | 656.9 | 326.9 |
| EBITA margin | 89.2% | 1.2% | 84.4% | 3.5% | 5.3% | 6.0% | 2.6% | 1.2% |
| Amortization of intangibles | | | | 11.9 | 10.2 | 6.8 | 4.2 | 3.5 |
| EBIT | 6,644.8 | 149.1 | 28,365.6 | 1,436.0 | 1,846.4 | 1,769.0 | 652.7 | 323.5 |
| EBIT margin | 89.2% | 1.2% | 84.4% | 3.5% | 5.3% | 5.9% | 2.6% | 1.2% |
| Pre-tax income | 581.7 | 291.2 | -59.4 | 1,089.9 | 566.4 | 1,251.2 | 407.4 | 148.9 |
| Income taxes | -90.5 | 84.0 | -189.1 | -194.1 | -178.4 | -278.0 | 4.4 | 4.6 |
| Tax rate | | 28.8% | 318.2% | | | | 1.1% | 3.1% |
| Net income | 0.0 | 235.3 | 0.0 | 721.0 | 230.4 | 898.7 | 406.5 | 141.7 |
| Net margin | 0.0% | 1.9% | 0.0% | 1.8% | 0.7% | 3.0% | 1.6% | 0.5% |
| |
| Diluted EPS | $0.00 | $1.17 | $0.00 | $3.50 | $1.29 | $5.31 | $2.63 | $1.08 |
| Shares outstanding (diluted) | 211.6 | 200.4 | 195.1 | 205.7 | 178.9 | 169.4 | 154.7 | 131.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|